A systematic review of cost-effectiveness analyses of pharmacogenetic-guided dosing in treatment with coumarin derivatives.
Verhoef TI, Redekop WK, Darba J, Geitona M, Hughes DA, Siebert U, de Boer A, Maitland-van der Zee AH, Barallon R, Briz M, Daly A, Haschke-Becher E, Kamali F, Kirchheiner J, Manolopoulos VG, Pirmohamed M, Rosendaal FR, van Schie RM, Wadelius M; EU-PACT Group.
Verhoef TI, et al.
Pharmacogenomics. 2010 Jul;11(7):989-1002. doi: 10.2217/pgs.10.74.
Pharmacogenomics. 2010.
PMID: 20602617
Review.